Literature DB >> 6124386

Identification of O-demethylated and ring-hydroxylated metabolites of methotrimeprazine (levomepromazine) in man.

H Johnsen, S G Dahl.   

Abstract

Nonenzymatic FeCl2-catalyzed oxidation of methotrimeprazine (levomepromazine) yielded three ring-hydroxylated derivatives that had different GC retention times but almost identical mass spectra. Two of these, together with O-desmethylmethotrimeprazine, were identified by combined GC/MS in enzymatically hydrolyzed urine from four psychiatric patients, who had been treated with oral doses of methotrimeprazine. The mass chromatograms indicated that the three metabolites were formed in similar amounts. Small amounts of three other metabolites were also found in the urine after enzymatic hydrolysis. These were identified as O-desmethyl-N-monodesmethylmethotrimeprazine and two monohydroxy-N-monodesmethyl derivatives that had different GC retention times. None of those metabolites were found in unconjugated form in the urine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6124386

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  5 in total

1.  Region specific distribution of levomepromazine in the human brain.

Authors:  J Kornhuber; H Weigmann; J Röhrich; J Wiltfang; S Bleich; I Meineke; R Zöchling; S Härtter; P Riederer; C Hiemke
Journal:  J Neural Transm (Vienna)       Date:  2005-07-06       Impact factor: 3.575

2.  Theoretical study on the metabolic mechanisms of levmepromazine by cytochrome P450.

Authors:  Yongting Wang; Qiu Chen; Zhiyu Xue; Yan Zhang; Zeqin Chen; Ying Xue
Journal:  J Mol Model       Date:  2016-09-13       Impact factor: 1.810

Review 3.  Plasma level monitoring of antipsychotic drugs. Clinical utility.

Authors:  S G Dahl
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

4.  Anti-apomorphine effects of phenothiazine drug metabolites.

Authors:  E Morel; K G Lloyd; S G Dahl
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Metabolism of levomepromazine in man.

Authors:  P A Hals; S G Dahl
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1995 Jan-Mar       Impact factor: 2.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.